AIDS Healthcare Foundation supports new implant to deliver HIV treatment
A team of scientists from the Oak Crest Institute of Science recently created a subdermal implant. This is the first of its kind, and it delivers antiretroviral drugs that prevent and treat HIV. The drugs are delivered inside the patient for up to 40 days.
“Numerous medical studies and our years of treating people living with HIV all over the world have proven to us that one of the most significant challenges in suppressing the virus is getting patients to take their medications every single day,” the AHF spokesperson said. “From the beginning of the debate on pre-exposure prophylaxis as a public health strategy, AHF has said that we would support a vaccine or implant that reduces the human tendency to skip doses. While patient studies, federal approval and information on pricing and availability is still needed at this early stage, the news that scientists have created the first implant to deliver HIV medications for prevention or treatment is a potential medical breakthrough that AHF wholeheartedly welcomes. We’ll be closely monitoring the next steps following these promising preliminary studies.”
Further details about the new implant are available in the Antimicrobial Agents and Chemotherapy report.